相关实验视频

Updated: Jun 5, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

在结核病治疗研究中的时间对阳性数据的分析:确定一个新的量化极限

Suzanne M Dufault¹, Geraint R Davies², Elin M Svensson³

¹Division of Biostatistics, University of California, San Francisco, San Francisco, California, USA; UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco, California, USA.

International journal of antimicrobial agents

|December 9, 2024

概括

在结核病 (TB) 诊断中为时间到阳性 (TTP) 设定较低的量化上限,可以提高模型精度和疗程歧视. 这表明超过25-30天的TTP值可能无法显著帮助结核病治疗反应的定量分析.

科学领域:

微生物学微生物学
临床试验临床试验
生物统计学生物统计学

背景情况:

巴克特克 (BACTEC) 菌根菌生长指标管 (MGIT) 系统是用于在唾液中检测菌根结核病菌的全球标准.
时间到阳性 (TTP) 是一个关键的诊断指标,样本通常评估长达42天.

研究的目的:

调查是否为建模设置一个较低的量化上限 (ULOQ_M) 可以改善TTP数据的分析.
评估ULOQ_M对结核病治疗方案的准确性和歧视性的影响.

主要方法:

来自TB-PACTS和PanACEA MAMS-TB随机临床试验的TTP数据的分析.
使用诊断检测极限 (LOD) 与较低的 ULOQ_M值 (25 和 30 天) 的建模方法的比较.

主要成果:

不到7.1%的样本有25至42天之间的TTP,预测误差在这个范围内最高.
使用25或30天的ULOQ_M的模型显示,与使用LOD相比,25个方案级坡度中的23个估计器精度有所提高.
当使用较低的ULOQ_M值时,治疗方案之间的歧视得到改善.

结论:

在25天和诊断LOD之间的TTP值可能对评估结核病治疗反应具有有限的定量价值.
使用较低的ULOQ_Ms可以提高临床试验分析的统计能力和准确性.
优化TTP分析可以使结核病临床试验更有效,更具信息性.

关键词:

生物标志物生物标志物临床试验中的临床试验.早期的细菌杀菌活性.增长指标管 (MGIT) 是一个指标管.量化的量化限制.这种细菌是Mycobacteria.时间到积极性的时间.结核病是一种疾病.

更多相关视频

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...